FDA Output March 2024
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in March 2024. Updated March 14.
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in March 2024. Updated March 14.
With a novel application of pulsed field ablation, Mirai Medical enables clinicians with GI endoscopy skills to safely treat the disease they find during screening and diagnostic procedures.
As the insulin patch-pump field becomes more crowded, user-oriented design features could emerge as important market differentiators, and ViCentra, a small OUS company with a unique pump form factor believes it has an edge in that regard.